The safety of antimicrobials for the treatment of community-acquired pneumonia-Reference-Cited by-同舟云学术

The safety of antimicrobials for the treatment of community-acquired pneumonia

Published:2020-04-17 Issue:5 Volume:19 Page:577-587
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Bastida Carla¹^ORCID,Soy Dolors¹²^ORCID,Torres Antoni²³⁴^ORCID

Affiliation:

1. Pharmacy Department, Division of Medicines, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain

2. Fundació Clínic per La Recerca Biomèdica (FCRB), Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain

3. Institute of Respiratory Disease, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain

4. ICREA Academia, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1750594

Reference60 articles.

1. Guía multidisciplinar para la valoración pronóstica, diagnóstico y tratamiento de la neumonía adquirida en la comunidad

2. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutical strategies in cavitary legionnaires’ disease, two cases from the field and a systematic review;Annals of Clinical Microbiology and Antimicrobials;2023-11-29